Deal sells units of shares, warrants at C$0.10 each via agent Trapeze
By Devika Patel
Knoxville, Tenn., May 12 - MedX Health Corp. said it raised C$350,000 in the second tranche of a C$2 million private placement of units. Trapeze Capital Corp. is the lead agent for the deal, which priced on Jan. 22 and raised C$565,000 on March 19.
The company is selling 20 million units of one common share and one warrant at C$0.10 per unit on a reasonable efforts basis. It sold 5.65 million units in the first tranche and 3.5 million units in the second.
The two-year warrants are each exercisable at C$0.20. The strike price is a 122.22% premium to the Jan. 21 closing share price of C$0.09.
Proceeds will be used for expansion of marketing efforts and general working capital purposes.
Based in Mississauga, Ont., MedX Health develops phototherapy medical devices.
| Issuer: | MedX Health Corp.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | C$2 million
|
| Units: | 20 million
|
| Price: | C$0.10
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | C$0.20
|
| Agent: | Trapeze Capital Corp. (lead)
|
| Pricing date: | Jan. 22
|
| Settlement date: | March 19 (for C$565,000), May 9 (for C$350,000)
|
| Stock symbol: | TSX Venture: MDX
|
| Stock price: | C$0.09 at close Jan. 21
|
| Market capitalization: | C$5.68 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
